Monica Bacci Selected Research

Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells

12/2019

Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica Bacci Research Topics

Disease

2	Thrombasthenia (Glanzmann Thrombasthenia) 01/2022 - 12/2019
2	COVID-19 05/2021 - 01/2021
1	Hemorrhage 01/2022
1	Sepsis (Septicemia) 05/2021
1	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells 12/2019
1	Pulmonary Embolism 01/2016
1	Atherosclerosis 07/2009
1	Rheumatoid Arthritis 07/2009
1	Inflammation (Inflammations) 07/2009
1	Atherosclerotic Plaque (Atheroma) 07/2009

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2022 - 07/2009
1	IntegrinsIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	PTX3 proteinIBA 05/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Rituximab (Mabthera)FDA Link 12/2019
1	Adenosine Diphosphate (ADP)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009
1	CytokinesIBA 07/2009
1	Infliximab (Remicade)FDA Link 07/2009

Therapy/Procedure

1	Aftercare (After-Treatment) 07/2009